Lazard Asset Management LLC Novo Cure LTD Transaction History

Lazard Asset Management LLC

$70 Billion
Q3 2025

A detailed history of Lazard Asset Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Lazard Asset Management LLC holds 10,115 shares of NVCR stock, worth $114,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,115

Previous 90,297 88.8%

Holding current value

$114,501

Previous $1.61 Million 91.91%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$10.9 - $18.46 $873,983 - $1.48 Million	-80,182 Reduced 88.8%	10,115 $130,000
Q2 2025 Aug 14, 2025	BUY	$15.37 - $19.4 $1.34 Million - $1.69 Million	87,021 Added 2656.32%	90,297 $1.61 Million
Q1 2025 May 15, 2025	SELL	$17.82 - $30.19 $8,642 - $14,642	-485 Reduced 12.9%	3,276 $58,000
Q4 2024 Feb 14, 2025	SELL	$14.54 - $33.41 $319 - $735	-22 Reduced 0.58%	3,761 $112,000
Q3 2024 Nov 14, 2024	BUY	$15.61 - $23.34 $58,756 - $87,851	3,764 Added 19810.53%	3,783 $59,000

Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $41,377 - $84,737	-1,027 Reduced 98.18%	19 $0
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $70,573 - $92,973	1,038 Added 12975.0%	1,046 $79,000
Q2 2022 Aug 09, 2022	SELL	$56.6 - $89.9 $75,957 - $120,645	-1,342 Reduced 99.41%	8 $0
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $50,706 - $71,250	843 Added 166.27%	1,350 $111,000
Q4 2021 Feb 09, 2022	SELL	$75.08 - $121.99 $1.1 Million - $1.79 Million	-14,659 Reduced 96.66%	507 $38,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $1.68 Million - $2.81 Million	14,440 Added 1988.98%	15,166 $1.76 Million
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $14,604 - $25,264	-112 Reduced 13.37%	726 $161,000
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $16,382 - $25,102	-132 Reduced 13.61%	838 $110,000
Q4 2020 Feb 11, 2021	SELL	$112.16 - $174.14 $98,364 - $152,720	-877 Reduced 47.48%	970 $167,000
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $18,750 - $35,953	-323 Reduced 14.88%	1,847 $205,000
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $28,714 - $37,353	-502 Reduced 18.79%	2,170 $128,000
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $118,606 - $199,064	2,079 Added 350.59%	2,672 $179,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $36,682 - $57,995	593 New	593 $44,000
Q1 2018 May 14, 2018	SELL	$19.3 - $23.65 $259,102 - $317,501	-13,425 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$16.3 - $21.9 $218,827 - $294,007	13,425	13,425 $271,000

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

74.2M

Call Options Held

1.26M

Put Options Held

247K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Novo Cure LTD Transaction History